Search

Risk of human papillomavirus (HPV) transmission during laser vaporisation of genital warts or loop electrode excision procedure is controversial. An oral rinse, a nasal swabs, history of HPV-related diseases and data on HPV exposure were collected from 287 employees at departments of dermato-venerology and gynaecology in Denmark. A mucosal HPV type was found among 5.8% of employees with experience of laser treatment of genital warts as compared to 1.7% of those with no experience (p = 0.12). HPV prevalence was not higher in employees participating in electrosurgical treatment or cryotherapy of genital warts, or loop electrode excision procedure compared with those who did not. HPV 6 or 11 were not detected in any samples. Hand warts after the age of 24 years was more common among dermatology than among non-dermatology personnel (18% vs. 8.0%, p = 0.03). Mucosal HPV types are infrequent in the oral and nasal cavity of health care personnel, however, employees at departments of dermato-venereology are at risk of acquiring hand warts. [ABSTRACT FROM AUTHOR]

The article presents a case study of a 71-year old male crematory operator presented to clinic in 2017 with severe actinic damage on the right side of his face, and had a history of multiple basal and squamous cell carcinomas on the scalp and face because of the unilateral actinic damage. The article discusses that crematory equipment was contaminated with a radiopharmaceutical, lutetium Lu 177 and a radioactive isotope, technetium Tc 99m, was detected in the urine of a crematory operator.

The article presents information regarding a study, evaluating the effect of discontinuation of folate antagonist, Methotrexate (MTX) for treatment of psoriasis. It informs that that the study reviewed the records of all patients of psoriasis, registered as having an international classification of disease (ICD 10) in the period of 1997-2007. It is concluded that the efficacy, prevalence and the severity of MTX depends on treatment dose.

The article presents a case study of a 52-year-old man with a long year history of chronic psoriatic arthritis involving multiple joints who developed hyperpigmentation of the face after treatment with adalimumab. Mild psoriasis limited to a single lesion was observed in the patient's ear before treatment. The authors note that hyperpigmentation remained unchanged after discontinuation of adalimumab and methotrexate (MTX).